How to contact the center
Full member
HCP Center
Tartu University Hospital is the largest health care provider in Estonia. High quality tertiary medical care is offered in nearly all specialities.
Tartu University Hospital is the only academic hospital in Estonia. It plays a major role in both undergraduate and postgraduate studies of medical fields. As the leading teaching hospital all the staff is trained to supervise students and residents from the Faculty of Medicine but also nursing students and collegues from other hospitals.
The third undoubtedly important part is research. In addition to everyday duties in serving patients and teaching the future medical specialists, Tartu University Hospital integrates work with scientific research. Education and research are undertaken in close collaboration with the Faculty of Medicine. Both, Faculty and University Hospital, are widely known by clinical trials and clinical research in human health. In addition, the tight co-operation between the University and the University Hospital creates mutual synergy between preclinical and clinical research.
Picture: Ivo Kruusamägi
Tartu University Hospital is the only academic hospital in Estonia. It plays a major role in both undergraduate and postgraduate studies of medical fields. As the leading teaching hospital all the staff is trained to supervise students and residents from the Faculty of Medicine but also nursing students and collegues from other hospitals.
The third undoubtedly important part is research. In addition to everyday duties in serving patients and teaching the future medical specialists, Tartu University Hospital integrates work with scientific research. Education and research are undertaken in close collaboration with the Faculty of Medicine. Both, Faculty and University Hospital, are widely known by clinical trials and clinical research in human health. In addition, the tight co-operation between the University and the University Hospital creates mutual synergy between preclinical and clinical research.
Picture: Ivo Kruusamägi
Contact
Clinical trials
NCT04435366 - Completed
A Phase 3 Multicenter, Randomized, Double Masked, Sham- Controlled Clinical Trial to Assess the Safety and Efficacy of Intravitreal Administration of Zimura (Complement C5 Inhibitor) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Interventional
NCT04423718 - Active, Not recruiting
Randomized, Double-Masked, Active-Controlled, Phase 3 Study of the Efficacy and Safety of High Dose Aflibercept in Patients With Neovascular Age-Related Macular Degeneration
Interventional
NCT04270747 - Completed
A Randomized, Double-masked, Phase 3 Study of ABP 938 Efficacy and Safety Compared to Aflibercept (Eylea®) in Subjects With Neovascular Age-related Macular Degeneration
Interventional
NCT04939571 - Recruiting, Active
European Disease Registry on Retinopathy of Prematurity (ROP)
Observational